Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity

The RXR heterodimers and orphan receptors

Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,133 · see citing works

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1× · see citing works

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C. A., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A. J., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,221 · see citing works

PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173 · see citing works

Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis

Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,009 · see citing works

A stable, radioactive substrate emulsion for assay of lipoprotein lipase

Nilsson‐Ehle, P., & Schotz, M. C. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41752-3 · Cited by 841 · see citing works

A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR

Mangelsdorf, D. J., Umesono, K., Kliewer, S. A., Borgmeyer, U., Ong, E. S., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(81)90018-0 · Cited by 647 · see citing works

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

Mukherjee, R., Davies, P. J., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., et al. (1997) · Nature · doi:10.1038/386407a0 · Cited by 598 · see citing works

Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3

Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539 · see citing works

Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists

Mukherjee, R., Jow, L., Croston, G. E., & Paterniti, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8071 · Cited by 421 · see citing works

Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids

Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E. M., Suto, C. M., Goldman, M. E., & Heyman, R. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00044a014 · Cited by 373 · see citing works

Retinoid Receptors

Mangelsdorf, D. J., Kliewer, S. A., Kakizuka, A., Umesono, K., & Evans, R. M. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50008-7 · Cited by 356 · see citing works

Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells

Boehm, M. F., Zhang, L., Zhi, L., McClurg, M. R., Berger, E. M., WAGONER, M., Mais, D. E., Suto, C. M., Davies, P. J. A., Heyman, R. A., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a018 · Cited by 342 · see citing works

Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.

Bershad, S., Rubinstein, A., Paterniti, J. R., Le, N.-A., Poliak, S. C., Heller, B., Ginsberg, H. N., Fleischmajer, R., & Brown, W. V. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131604 · Cited by 217 · cited 1× · see citing works

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.

Miller, V. A., Benedetti, F. M., Rigas, J. R., Verret, A. L., Pfister, D. G., Straus, D., Kris, M. G., Crisp, M., Heyman, R. A., Loewen, G. R., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.790 · Cited by 185 · see citing works

Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo

Merkel, M., Kako, Y., Radner, H., Cho, I. S., Ramasamy, R., Brunzell, J. D., Goldberg, I. J., & Breslow, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13841 · Cited by 150 · see citing works

Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

Vu-Dac, N., Gervois, P., Torra, I. P., Fruchart, J. C., Kosykh, V, Kooistra, T., Princen, H. M., Dallongeville, J., & Staels, B. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1581 · Cited by 143 · see citing works

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

Lefebvre, A., Peinado‐Onsurbe, J., Leitersdorf, I., Briggs, M. R., Paterniti, J. R., Fruchart, J., Fiévet, C., Auwerx, J. H., & Staels, B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1756 · Cited by 143 · see citing works

Regulation of Triglyceride Metabolism by PPARs : Fibrates and Thiazolidinediones have Distinct Effects

Auwerx, J. H., Schoonjans, K., Fruchart, J., & Staels, B. (1996) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.3.81 · Cited by 110 · see citing works

A Phase I study of LGD1069 in adults with advanced cancer.

Rizvi, N. A., Marshall, J. L., Dahut, W., Ness, E. A., Truglia, J. A., Loewen, G. R., Gill, G. M., Ulm, E. H., Geiser, R., Jaunakais, D., et al. (1999) · PubMed · Cited by 101 · see citing works

RXR Agonists Activate PPARα-Inducible Genes, Lower Triglycerides, and Raise HDL Levels In Vivo

Mukherjee, R., Strasser, J., Jow, L., Hoener, P. A., Paterniti, J. R., & Heyman, R. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.272 · Cited by 89 · see citing works

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

Lenhard, J. M., Lancaster, M. E., Paulik, M. A., Weiel, J. E., Binz, J. G., Sundseth, S. S., Gaskill, B., Lightfoot, R. M., & Brown, H. R. (1999) · Diabetologia · doi:10.1007/s001250051193 · Cited by 82 · see citing works

Effect of oral 13-cis-retinoic acid on serum lipids

LYONS, F., Laker, M. F., Marsden, J. R., MANUEL, R., & Shuster, S. (1982) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1982.tb00411.x · Cited by 72 · see citing works

Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.

Duverger, N., Ghalim, N., Ailhaud, G. P., Steinmetz, A., Fruchart, J., & Castro, G. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.1.126 · Cited by 65 · see citing works

Retinoid-Induced Hypertriglyceridemia in Rats Is Mediated by Retinoic Acid Receptors

Standeven, A. M. (1996) · Fundamental and Applied Toxicology · doi:10.1006/faat.1996.0164 · Cited by 64 · see citing works

High-resolution solution structure of the retinoid X receptor DNA-binding domain

Holmbeck, S. M. A., Foster, M. P., Casimiro, D. R., Sem, D. S., Dyson, H. J., & Wright, P. E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1908 · Cited by 61 · see citing works

Retinoids Increase Human Apolipoprotein A-II Expression through Activation of the Retinoid X Receptor but Not the Retinoic Acid Receptor

Vu‐Dac, N., Schoonjans, K., Kosykh, V., Dallongeville, J., Heyman, R. A., Staels, B., & Auwerx, J. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3350 · Cited by 59 · see citing works

Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy.

McCarter, T. L., & Chen, Y. K. (1992) · PubMed · Cited by 53 · see citing works

Thiazolidinediones Inhibit Lipoprotein Lipase Activity in Adipocytes

Ranganathan, S., & Kern, P. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26117 · Cited by 47 · see citing works

Lipoprotein lipase gene expression in THP-1 cells

Auwerx, J. H., Deeb, S. S., Brunzell, J. D., Wolfbauer, G., & Chait, A. (1989) · Biochemistry · doi:10.1021/bi00437a009 · Cited by 43 · see citing works

Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region

Kern, P. A., Ranganathan, G., Yukht, A., Ong, J. M., & Davis, R. C. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37482-4 · Cited by 38 · see citing works

Relapsed Acute Promyelocytic Leukemia Previously Treated with All-Trans Retinoic Acid: Clinical Experience with a New Synthetic Retinoid, Am-80

Takeuchi, M., Yano, T., Omoto, E., Takahashi, K., Kibata, M., Shudo, K., Harada, M., Uedad, R., & Ohno, R. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057604 · Cited by 35 · see citing works

RETINOIC ACID AND HYPERTRIGLYCERIDEMIA

Gerber, L. E., & Erdman, J. W. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb12766.x · Cited by 34 · see citing works

Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.

NDuverger, NGhalim, GAilhaud, ASteinmetz, CFruchart, J., & GCastro (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 31 · see citing works

Starvation enhances lipoprotein lipase activity in the liver of the newborn rat

Grinberg, D., Ramı́rez, I., Vilaró, S., Reina, M., Llobera, M., & Herrera, E. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90193-6 · Cited by 30 · see citing works

Hyperlipidemia in rats fed retinoic acid

Gerber, L. E., & Erdman, J. W. (1981) · Lipids · doi:10.1007/bf02535047 · Cited by 27 · see citing works

Biotransformation of 13-cis- and 9-cis-retinoic acid to all-trans-retinoic acid in rat conceptal homogenates. Evidence for catalysis by a conceptal isomerase.

Chen, H., & Juchau, M. R. (1998) · PubMed · Cited by 26 · see citing works

Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin

Vahlquist, C., Lithell, H., MICHAELSSON, G., Selinus, I., Vahlquist, A., & Vessby, B. (1987) · Acta Dermato Venereologica · doi:10.2340/0001555567139144 · Cited by 24 · see citing works

Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia

Gehrisch, S., Kostka, H., Tiebel, M., Patzak, A., Paetzold, A., Julius, U., Schroeder, H., Markolf Hanefeld, E., & Jaroß, W. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900053 · Cited by 17 · see citing works

Increased Intracellular Triglyceride in C2C12 Muscle Cells Transfected with Human Lipoprotein Lipase

Poirier, P., Marcell, T., Huey, P. U., Schlaepfer, I. R., Owens, G. C., Jensen, D. R., & Eckel, R. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2528 · Cited by 12 · see citing works

Effects of retinoic acid on lipoprotein lipase activity and mRNA level in vitro and in vivo

Oliver, J. D., & Rogers, M. P. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90130-o · Cited by 10 · see citing works

Effects of isotretinoin on lipid metabolism in the rat

McMaster, J., Rogers, M. P., Sherratt, H. S. A., & Shuster, S. (1989) · Archives of Dermatological Research · doi:10.1007/bf00426589 · Cited by 4 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Lipoprotein lipase: from gene to obesity

Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 862 · see citing works

Nuclear Receptors and the Control of Metabolism

Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 632 · see citing works

Physiological regulation of lipoprotein lipase

Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 548 · see citing works

RAR and RXR modulation in cancer and metabolic disease

Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2397 · Cited by 517 · see citing works

PPARγ AND G LUCOSE H OMEOSTASIS

Picard, F., & Auwerx, J. H. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 412 · see citing works

Retinoid X receptors: X-ploring their (patho)physiological functions

Szántó, A., Narkar, V. A., Shen, Q., Uray, I. P., Davies, P. J., & Nagy, L. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401533 · Cited by 304 · see citing works

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

Cao, G., Yu, L., Broderick, C. L., Oldham, B. A., Beyer, T., Schmidt, R. J., Zhang, Y., Stayrook, K. R., Suen, C. S., Otto, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210208200 · Cited by 298 · see citing works

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

Claudel, T., Leibowitz, M. D., Fiévet, C., Tailleux, A., Wagner, B. L., Repa, J. J., Torpier, G., Lobaccaro, J. A., Paterniti, J. R., Mangelsdorf, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609298 · Cited by 292 · see citing works

Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism

Preiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 240 · see citing works

Lipid metabolism in mammalian tissues and its control by retinoic acid

Bonet, M. L., Ribot, J., & Palou, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.001 · Cited by 212 · see citing works

Regulation of lipoprotein lipase by Angptl4

Dijk, W., & Kersten, S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.12.005 · Cited by 199 · see citing works

Pharmacotherapy for dyslipidaemia ? current therapies and future agents

Bays, H. E., & Stein, E. A. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1901 · Cited by 171 · see citing works

Modulation of RXR function through ligand design

Pérez, E., Bourguet, W., Gronemeyer, H., & de Lera, A. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.04.003 · Cited by 169 · see citing works

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis

Lund, E. G., Menke, J. G., & Sparrow, C. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000056743.42348.59 · Cited by 131 · see citing works

The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.

Ahuja, H. S., Szántó, A., Nagy, L., & Davies, P. J. (2003) · PubMed · Cited by 128 · see citing works

PPAR∞ AND GLUCOSE HOMEOSTASIS

Auwerx, J. H. (2002) · Cited by 127 · see citing works

Retinaldehyde Dehydrogenase 1 Coordinates Hepatic Gluconeogenesis and Lipid Metabolism

Kiefer, F. W., Orasanu, G., Nallamshetty, S., Brown, J. D., Wang, H., Luger, P., Qi, N., Burant, C., Duester, G., & Plutzky, J. (2012) · Endocrinology · doi:10.1210/en.2011-2104 · Cited by 111 · see citing works

RXR: From Partnership to Leadership in Metabolic Regulations

Desvergne, B. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75001-4 · Cited by 107 · see citing works

Retinoic Acid Treatment Enhances Lipid Oxidation and Inhibits Lipid Biosynthesis Capacities in the Liver of Mice

Amengual, J., Ribot, J., Bonet, M. L., & Palou, A. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315085 · Cited by 107 · see citing works

Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis

Preitner, F., Mody, N., Graham, T. E., Peroni, O. D., & Kahn, B. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2009 · Cited by 106 · see citing works

The pivotal role of lipoprotein lipase in atherosclerosis

Mead, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00405-4 · Cited by 106 · see citing works

Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators

le Maire, A., Álvarez, S., Shankaranarayanan, P., de Lera, Á. R., Bourguet, W., & Gronemeyer, H. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436687 · Cited by 106 · see citing works

Lipoprotein lipase and atherosclerosis

Stein, Y. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00014-5 · Cited by 83 · see citing works

Rexinoid Bexarotene Modulates Triglyceride but not Cholesterol Metabolism via Gene-Specific Permissivity of the RXR/LXR Heterodimer in the Liver

Lalloyer, F., Pedersen, T. Å., Gross, B. S., Lestavel, S., Yous, S., Vallez, E., Gustafsson, J.-Α., Mandrup, S., Fiévet, C., Staels, B., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.189506 · Cited by 76 · see citing works

Retinoid Metabolism and Diabetes Mellitus

Rhee, E., & Plutzky, J. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.167 · Cited by 73 · see citing works

Mechanism of Selective Retinoid X Receptor Agonist-Induced Hypothyroidism in the Rat

Liu, S., Ogilvie, K. M., Klausing, K., Lawson, M. A., Jolley, D., Li, D., Bilakovics, J. M., Pascual, B., Hein, N., Urcan, M. S., et al. (2002) · Endocrinology · doi:10.1210/endo.143.8.8930 · Cited by 75 · see citing works

Antioxidant Vitamins and Lipid Therapy

Brown, B. G., Cheung, M. C., Lee, A. C., Zhao, X.-Q., & Chait, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034706.24149.95 · Cited by 75 · see citing works

Thrombosis and Hemostatic Abnormalities in Hematological Malignancies

Colombo, R., Gallipoli, P., & Castelli, R. (2014) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2014.05.003 · Cited by 71 · see citing works

Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes

Leibowitz, M. D., Ardecky, R., Boehm, M. F., Broderick, C. L., Carfagna, M. A., Crombie, D. L., D’Arrigo, J., Etgen, G. J., Faul, M. M., Grese, T. A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0690 · Cited by 71 · see citing works

(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice

Zhang, Y., Zhang, H., Yao, X., Shen, H., Chen, J., Li, C., Chen, L., Zheng, M., Ye, J., Hu, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031811 · Cited by 67 · see citing works

Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome

Pinaire, J. A., & Reifel-Miller, A. E. (2007) · PPAR Research · doi:10.1155/2007/94156 · Cited by 62 · see citing works

Angiopoietin-Like 4 Mediates PPAR Delta Effect on Lipoprotein Lipase-Dependent Fatty Acid Uptake but Not on Beta-Oxidation in Myotubes

Robciuc, M. R., Skrobuk, P., Anisimov, A., Olkkonen, V. M., Alitalo, K. K., Eckel, R. H., Koistinen, H. A., Jauhiainen, M., & Ehnholm, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046212 · Cited by 61 · see citing works

Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor γ and Retinoic Acid X Receptors

Li, X., Hansen, P. A., Li, X., Chandraratna, R. A. S., & Burant, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505853200 · Cited by 60 · see citing works

Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet

Haugen, B. R., Jensen, D. R., Sharma, V., Pulawa, L. K., Hays, W. R., Krężel, W., Chambon, P., & Eckel, R. H. (2004) · Endocrinology · doi:10.1210/en.2003-1401 · Cited by 54 · see citing works

Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjects

Golden, W. M., Weber, K. B., Hernandez, T. L., Sherman, S. I., Woodmansee, W. W., & Haugen, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0696 · Cited by 53 · see citing works

Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice

Shen, Q., Cline, G. W., Shulman, G. I., Leibowitz, M. D., & Davies, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311729200 · Cited by 53 · see citing works

Roles of vitamin A status and retinoids in glucose and fatty acid metabolism

Zhao, S., Li, R., Yang, L., Chen, W., Zhang, Y., & Chen, G. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-079 · Cited by 52 · see citing works

RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists

Kakuta, H., Yakushiji, N., Shinozaki, R., Ohsawa, F., Yamada, S., Ohta, Y., Kawata, K., Nakayama, M., Hagaya, M., Fujiwara, C., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300055n · Cited by 50 · see citing works

Vitamin A regulates obesity in WNIN/Ob obese rat; independent of stearoyl-CoA desaturase-1

Jeyakumar, S. M., Vajreswari, A., & Giridharan, N. V. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.073 · Cited by 48 · see citing works

Mechanism of Retinoid X Receptor Partial Agonistic Action of 1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic Acid and Structural Development To Increase Potency

Ohsawa, F., Yamada, S., Yakushiji, N., Shinozaki, R., Nakayama, M., Kawata, K., Hagaya, M., Kobayashi, T., Kohara, K., Furusawa, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400033f · Cited by 47 · see citing works

Vitamin A as a key regulator of obesity & its associated disorders: Evidences from an obese rat model

Jeyakumar, S. M., & Vajreswari, A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.156554 · Cited by 45 · see citing works

Epigenetic approach in obesity: DNA methylation in a prepubertal population which underwent a lifestyle modification

Gallardo‐Escribano, C., Buonaiuto, V. A., Ruiz-Moreno, M. I., Vargas‐Candela, A., Vilches-Pérez, A., Benítez‐Porres, J., Romance-García, Á. R., Ruiz-Moreno, A., Gómez‐Huelgas, R., & Bernal-López, M. R. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00935-0 · Cited by 44 · see citing works

Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors

Anakk, S., Kalsotra, A., Shen, Q., Vu, M. T., Staudinger, J. L., Davies, P. J., & Strobel, H. W. (2003) · The FASEB Journal · doi:10.1096/fj.02-1004fje · Cited by 37 · see citing works

Retinoid X Receptor Heterodimer Variants and Cardiovascular Risk Factors

Nohara, A., Kobayashi, J., & Mabuchi, H. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no786 · Cited by 37 · see citing works

RXR activators molecular signalling: involvement of a PPARα‐dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart

Ouamrane, L., Larrieu, G., Gauthier, B. E., & Pineau, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705113 · Cited by 35 · see citing works

Activation of the Retinoid X Receptor Suppresses Appetite in the Rat

Ogilvie, K. M., Saladin, R., Nagy, T. R., Urcan, M. S., Heyman, R. A., & Leibowitz, M. D. (2003) · Endocrinology · doi:10.1210/en.2003-0907 · Cited by 34 · see citing works

Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation

Fujii, S., Ohsawa, F., Yamada, S., Shinozaki, R., Fukai, R., Makishima, M., Enomoto, S., Tai, A., & Kakuta, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.012 · Cited by 33 · see citing works

Beneficial effect of acitretin in Chanarin-Dorfman syndrome

Israeli, S., Pessach, Y., Sarig, O., Goldberg, I., & Sprecher, E. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04164.x · Cited by 32 · see citing works

The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease

Chen, G. (2015) · Current Drug Targets · doi:10.2174/1389450116666150325231015 · Cited by 32 · see citing works

Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers

Ohsawa, F., Morishita, K., Yamada, S., Makishima, M., & Kakuta, H. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100184k · Cited by 31 · see citing works

PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia

Li, K., Wang, F., Yang, Z.-N., Cui, B., Li, P., Li, Z., Hu, Z., & Zhu, H.-H. (2020) · Theranostics · doi:10.7150/thno.45924 · Cited by 30 · see citing works

Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis

Tailleux, A., Torpier, G., Mezdour, H., Fruchart, J., Staels, B., & Fiévet, C. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.08.001 · Cited by 28 · see citing works

Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer

Leal, A. S., Hung, P., Chowdhury, A. S., & Liby, K. T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108561 · Cited by 27 · see citing works

Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the “Prime Time” of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?

Yang, H. J., Xiao, L., & Xu, D. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07001-0 · Cited by 26 · see citing works

Potential therapeutic uses of rexinoids

Leal, A. S., Reich, L. A., Moerland, J. A., Zhang, D., & Liby, K. T. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.01.004 · Cited by 24 · see citing works

Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance

Chen, G. (2013) · ISRN Hepatology · doi:10.1155/2013/534972 · Cited by 23 · see citing works

High Frequency of a Retinoid X Receptor γ Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia

Nohara, A., Kawashiri, M., Claudel, T., Mizuno, M., Tsuchida, M., Takata, M., Katsuda, S., Miwa, K., Inazu, A., Kuipers, F., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000258945.76141.8a · Cited by 23 · see citing works

The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice

Cao, M., Royce, D. B., Risingsong, R., Williams, C. R., Sporn, M. B., & Liby, K. T. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0325 · Cited by 23 · see citing works

RXR Partial Agonist Produced by Side Chain Repositioning of Alkoxy RXR Full Agonist Retains Antitype 2 Diabetes Activity without the Adverse Effects

Kawata, K., Morishita, K., Nakayama, M., Yamada, S., Kobayashi, T., Furusawa, Y., Arimoto‐Kobayashi, S., Oohashi, T., Makishima, M., Naitou, H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501863r · Cited by 23 · see citing works

Vitamin A deficiency suppresses high fructose-induced triglyceride synthesis and elevates resolvin D1 levels

Reddy, M. R. G., Chodisetti, P. K., Mahesh, M., Kumar, M. S., Mullapudi, S. V., Putcha, U. K., Vajreswari, A., & Jeyakumar, S. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.11.005 · Cited by 21 · see citing works

Supplementation with 9-cis β-carotene-rich alga Dunaliella improves hyperglycemia and adipose tissue inflammation in diabetic mice

Harari, A., Harats, D., Marko, D., Cohen, H., Barshack, I., Gonen, A., Ben‐Shushan, D., Kamari, Y., Ben‐Amotz, A., & Shaish, A. (2012) · Journal of Applied Phycology · doi:10.1007/s10811-012-9903-4 · Cited by 20 · see citing works

A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart

Wu, G., Zhang, L., Gupta, J., Olivecrona, G., & Olivecrona, T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00634.2006 · Cited by 19 · see citing works

Associations between genetic variants and the severity of metabolic syndrome in subjects with type 2 diabetes

Chen, Y. L., Pei, D., Hung, Y. J., Lee, C., Hsiao, F., Wu, C., Lin, J., Hsu, C., Chang, J.-L., & Hsieh, C. H. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.30.10 · Cited by 19 · see citing works

A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy

Weber, S. R., Zhao, Y., Ma, J., Gates, C., Leprevost, F. D. V., Basrur, V., Nesvizhskii, A. I., Gardner, T. W., & Sundstrom, J. M. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09328-8 · Cited by 17 · see citing works

Transgenic Expression and Genetic Variation of Lmf1 Affect LPL Activity in Mice and Humans

Hosseini, M., Ehrhardt, N., Weissglas‐Volkov, D., Lai, C.-M., Mao, H. Z., Liao, J., Nikkola, E., Bensadoun, A., Taskinen, M., Doolittle, M. H., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.245696 · Cited by 18 · see citing works

Association between retinoid-X receptor-gamma genetic polymorphisms and diabetic retinopathy

Hsieh, C., Pei, D., Hung, Y., & Hsiao, F. (2011) · Genetics and Molecular Research · doi:10.4238/2011.december.5.4 · Cited by 16 · see citing works

Disease-causing mutations in genes encoding transcription factors critical for photoreceptor development

Sun, C., & Chen, S. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1134839 · Cited by 12 · see citing works

Retroperitoneal white adipose tissue lipoprotein lipase activity is rapidly down-regulated in response to acute stress

Casanovas, A., Parramon, N., de la Cruz, F., Andres, O. M. M. S., Terencio, J. V., López-Tejero, M. D., & Llobera, M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600487-jlr200 · Cited by 14 · see citing works

Increased Systemic Glucose Tolerance with Increased Muscle Glucose Uptake in Transgenic Mice Overexpressing RXRγ in Skeletal Muscle

Sugita, S., Kamei, Y., Akaike, F., Suganami, T., Kanai, S., Hattori, M., Manabe, Y., FUJII, N. L., Takai‐Igarashi, T., Tadaishi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020467 · Cited by 12 · see citing works

BMP and RA signaling cooperate to regulate Apolipoprotein C1 expression during embryonic development

Wang, Y., Li, W.-H., Li, Z., Liu, W., Zhou, L., & Gui, J. (2014) · Gene · doi:10.1016/j.gene.2014.10.047 · Cited by 11 · see citing works

Design, synthesis and biological evaluation of acyl hydrazones-based derivatives as RXRα-targeted anti-mitotic agents

Wang, Q., Tu, X., Wang, X., Cai, Q., Yu, L., Zhang, X. K., Yi, J., Wu, Y., Xie, G., Yuan, H., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106069 · Cited by 8 · see citing works

Association between Single-nucleotide Polymorphisms of RXRG and Genetic Susceptibility to Type 2 Diabetes in South China

Yu, H., Wang, S., Hu, W., Xu, L., Ding, Y., Kong, D., & Pan, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524020666191206163951 · Cited by 7 · see citing works

Exploring the combined therapeutic efficacy of bexarotene and icariin in type 2 diabetic rats

Dik, B., Parlak, T. M., Ateş, M. B., & Tufan, Ö. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae100 · Cited by 6 · see citing works

Retinoid-Induced Hyperlipidemia and the Risk of Atherosclerosis

Vahlquist, A. (2007) · Basic and clinical dermatology · doi:10.3109/9781420021189.014 · Cited by 6 · see citing works

The role of retinoids and their receptors in metabolic disorders

Meißburger, B., & Wolfrum, C. (2008) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200700291 · Cited by 4 · see citing works

Morbid obesity and its comorbidities

Peinado‐Onsurbe, J. (2018) · International Clinical Pathology Journal · doi:10.15406/icpjl.2018.06.00169 · Cited by 4 · see citing works

Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats

Ogasawara, A., Murakami, Y., Yakushiji, N., Ohsawa, F., Kusaba, J.-I., Aiba, T., Kurosaki, Y., & Kakuta, H. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.559247 · Cited by 3 · see citing works

Challenge of Creating Single-agents for the Treatment of Type 1 and 2 Diabetes by Targeting Retinoid X Receptor

Kakuta, H. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.917 · Cited by 3 · see citing works

Metabolic Diseases Drug Discovery World Summit

Liu, G. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.2.577 · Cited by 3 · see citing works

RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to Bexarotene

Chowdhury, A. S., Reich, L. A., Liby, K. T., Yeh, E. S., & Leal, A. S. (2025) · Biomedicines · doi:10.3390/biomedicines14010080 · Cited by 1 · see citing works

Vitamin-A-Spiegel unter langfristiger parenteraler Ernährung

Bohnert, H. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13195

Cellular immunity and inflammation in atherosclerosis

Wuttge, D. M. (2001) · Figshare

Retinoids, Hyperlipid- emia and Athero- sclerosis: Where Do We Stand Today?

Vahlquist, A. (2004)

Examining the relationship between Vitamin A intake and weight management

Eastep, J. (2016)

Intracellular & extracellular lipolysis : regulation by the PPAR targets ANGPTL4 & HILPDA

Dijk, W. (2016) · doi:10.18174/391415

Vitamin A’s Role in the Regulation of Hepatic Glucose and Lipid Metabolism During the Transition from Fasting to Refeeding

Li, Y., Li, R., & Chen, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-55387-0_92

Vitamin A’s Role in the Regulation of Hepatic Glucose and Lipid Metabolism During the Transition from Fasting to Refeeding

Li, Y., Li, R., & Chen, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-40007-5_92-1

Comparative evaluation of the biological characteristics of a novel retinoid X receptor agonist and bexarotene

Tomita, K., Nakashima, K., Yamaguchi, E., Itoh, A., Tsutsumiuchi, K., & Inoue, M. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100057

BindingDB Entry 50033069: Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers.

BindingDB (2011) · UC San Diego · doi:10.7270/q28s4q6x

BindingDB Entry 50032147: Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.

BindingDB (2011) · UC San Diego · doi:10.7270/q20g3kb3

BindingDB Entry 50040274: RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.

BindingDB (2013) · UC San Diego · doi:10.7270/q2c24xh4

BindingDB Entry 50042716: Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.

BindingDB (2013) · UC San Diego · doi:10.7270/q2348mr8

Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet

Haugen, B. R., Jensen, D. R., Sharma, V., Pulawa, L. K., Hays, W. R., Krężel, W., Chambon, P., & Eckel, R. H. (2004) · Endocrinology · doi:10.1210/en.2003-1401 · Cited by 54 · see citing works

Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.

Gouni, I., Oka, K., Etienne, J., & Chan, L. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41327-6 · Cited by 64 · see citing works

Differential Effects of Rexinoids and Thiazolidinediones on Metabolic Gene Expression in Diabetic Rodents

Ahuja, H. S., Liu, S., Crombie, D. L., Boehm, M. F., Leibowitz, M. D., Heyman, R. A., Depré, C., Nagy, L., Tontonoz, P., & Davies, P. J. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.765 · Cited by 108 · see citing works

Lipoprotein lipase enzyme expression in 3T3-L1 adipocytes is posttranscriptionally down-regulated by retinoic acid.

Kamei, Y., Kawada, T., Fujita, A., Etinne, J., Noé, L., & Sugimoto, E. (1992) · PubMed · Cited by 9 · see citing works

Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.

Noguchi, Y., Vydelingum, N., Younes, R. N., Fried, S. K., & Brennan, M. F. (1991) · PubMed · Cited by 44 · see citing works